series-c-plus
Stage
2008
Founded
2
Investors
About
CytomX Therapeutics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer and immune diseases.
Explore CytomX Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.